Commentary

Viable Third-Party Review System Required for Drug Makers’ Advertisements

Lexicon

Z2 Rule:
Z2(ゼットツー)

The Column

The Mastery of Recruitment

Archives

ASCO Immunotherapy Roundup - 1: Opdivo Data Boost Confidence in BMS’s Combination Strategy(Jul.07)
Series: ASCO Immunotherapy Roundup(Jul.07)
Viable Third-Party Review System Required for Drug Makers’ Advertisements(Jul.07)
Govt to Stockpile Pre-Pandemic Flu Vaccine Based on Indonesia Strain in FY2015(Jul.07)
Japan, US, Europe Anti-Infective Agent Markets Grow 48.4% in FY2014 Driven by Anti-HCV Treatments: Survey(Jul.07)

News Calendar